CR EOYS6 Flashcards
Which factor, if in excess can cause of a hypercoagulable state
Factor X
Factor VII
Factor VIII
Factor IX
Which factor, if in excess can cause a of hypercoagulable state
Factor X
Factor VII
Factor VIII
Factor IX
Which one of the following is not a cause of a hypercoagulable state
Elevated factor VIII
Malignancy
Protein C deficiency
Antiphospholipid syndrome
Elevated factor Xa
Which one of the following is not a cause of a hypercoagulable state
Elevated factor VIII
Malignancy
Protein C deficiency
Antiphospholipid syndrome
Elevated factor Xa
Which of the following would you prescribe alongside aspirin for NSTEMI treatment
Clopidogrel
Prasugrel
Ticagrelor
Abciximab
Which of the following would you prescribe alongside aspirin for NSTEMI treatment
Clopidogrel - (clopidogrel 300mg is an alternative if higher bleeding risk)
Prasugrel
Ticagrelor
Abciximab
Name the receptor on platelets that is activated by ADP
P2Y12
COX-1
TXA2
Glycoprotein IIb/IIIa
Name the receptor on platelets that is activated by ADP
P2Y12
COX-1
TXA2
Glycoprotein IIb/IIIa
Which of the following acts a receptor for von Willebrand Factor (vWF)
P2Y12
COX-1
TXA2
Glycoprotein Ib
Which of the following acts a receptor for von Willebrand Factor (vWF)
P2Y12
COX-1
TXA2
Glycoprotein Ib
This diagram depicts platelet adhesion to endothelium
Which of the following is VWF
A
B
C
D
This diagram depicts platelet adhesion to endothelium
Which of the following is VWF
A
B
C
D
glycoprotein IIb/IIIa (GPIIb/IIIa) an integrin complex found on platelets. It is a receptor for fibrinogen[1] and von Willebrand factor and aids platelet activation. The complex is formed via calcium-dependent association of gpIIb and gpIIIa, a required step in normal platelet aggregation and endothelial adherence
This diagram depicts platelet adhesion to endothelium
Which of the following is fibrinogen
A
B
C
D
This diagram depicts platelet adhesion to endothelium
Which of the following is fibrinogen
A
B
C
D
This diagram depicts platelet adhesion to endothelium
Which of the following is GpIIb/IIIa
A
B
C
D
This diagram depicts platelet adhesion to endothelium
Which of the following is GpIIb/IIIa
A
B
C
D
This diagram depicts platelet adhesion to endothelium
Which of the following is GpIb
A
B
C
D
This diagram depicts platelet adhesion to endothelium
Which of the following is GpIb
A
B
C
D
Bleeding from mucosal surfaces (epistaxis, gum bleeding, menorrhagia) would indicate
VWD
Factor deficiency
Bleeding from mucosal surfaces (epistaxis, gum bleeding, menorrhagia) would indicate
VWD
Factor deficiency - rate
This brusing would indicate
VWD
Factor deficiency
This brusing would indicate
VWD - small / multiple
Factor deficiency - one large bruise
What underlying pathologies might cause angina if the problem is occuring from a reduced o2 supply? [2]
Reduced O2 demand:
-
CAD:
- Atherosclerosis
- Post radiation therapy
- Spasm: normal coronary arteries which spasm causing temporary occlusion - Anaemia
What underlying pathologies might cause angina if the problem is occuring from an increased myocardial demand? [3]
- Left ventricular hypertrophy (from: HTN, aortic stenosis, aortic regurgiation, hypertrophic cardiomyopathy)
- Right ventricular hypertophy (from: pulmonary HTN, pulmnonary stenosis)
- Rapid tachycardiarythmias
Describe the pathway you would undertake to diagnose stable angina
Clinical assesment:
How many of the following do they have?
- General chest discomfort lasting 5/10 mins?
- Is this provoked by exercise?
- Is this relieved by rest or nitrates?
- Answer = <1, No diagnostic testing, no medication
- Answer = 2 characteristics = atypical angina
- Answer = 3 characteristics = typical angina
If Atypical angina or typical angina: initial management and investigations:
- CTCA
- Functional imaging if CTCA inconclusive
Describe the managment pathway for someone with angina
How do different drugs / therapies target different physiological areas to relieve angina symptoms?
Increasing O2 delivery
Increase coronary blood flow:
- Nitrates
- CCBs
- Revasc.
- Nicorandil (Combination of K+ blocker and nitrate)
Reducing myocardial demand:
1. Reduce HR:
- BB
- ivabradine (funny current (If) inhibitor)
2. Decrease LV wall tension:
- BB
- Nitrates
- Nicorandil
- CCBs
- Ranolazine (Na+ pump inhibitor)
3. Reduce contractility:
- BB
- CCBs
4. Modify energy metabolism
- Trimetazidine
How can you pharmacologically reduce risk of MI for patients who are at risk of angina? [4]
- Aspirin: this produces an antithrombotic effect that helps to reduce the risk of heart attacks and strokes.
- Statins: reduces cholesterol (HMG Reductase inhibitor)
- Ace Inhibitor: If there is hypertension or diabetes or other comorbidities
-
P2Y12 receptor
antagonist: After PCI or if allergic to statins (P2Y12 receptor blockers are another group of antiplatelet drugs. This group of drugs includes: clopidogrel, ticlopidine, ticagrelor, prasugrel, and cangrelor)
What drug is initially used to treat stable angina? [1]
glyceryl trinitrate (GTN).
What are 3 risk factors for thromboembolism - what is the name for these factors combined? [4]
Virchow’s Triad
Endothelial injury
Stasis or turbulence of blood flow
Blood hypercoagulability
Inflammation: causes procaogulant state - acts in combination with one of the above
Why does vein wall pathology increase chance of DVT / PE?
How can vein wall pathology / damage occur? [3]
Heparan sulfate projects out of the endothelial wall. These projections prevent platelet adhesion to intact endothelial membrane. If damaged - less heparan sulfate:
- increases risk of clot formation, especially if combined with reduced blood flow
Vein wall pathology can occur from:
a) smoking / alchohol
b) diabetes
c) chronic inflam disease (RA)
How do you diagnose DVT?
Use Wells’ Score:
- Add up points on the score: 2 points or more is likely. 1 is unlikely
- If 2 or more score: have proximal leg vein ultrasound
i) have positive scan - give treatment
iI) have negative scan, repeat in 6-8 days - do a D Dimer test
a) if D-dimer is positive: repeat scan in 6-8 days
b) if second sacan D-dimer is negative - consider alternative disease, but discuss symptoms with patient so they can look out for it - Venography - gold standard
* o D-dimer is fibrin degradation product
o Is a marker of fibrin formation
o Raised in VTE and other pathologies
D dimer: fibrin degradation product released when thrombus is degraded by by fibrinolysis low D dimer = low DVT risk.
Why might someone have hypercoaguable blood? [3]
When would you consider hypercoagulable states for DVT?
Why might someone have hypercoaguable blood?
- Antithrombin deficiency
- Protein C or S defiency (anti-coagulant proteins)
- Factor V Leiden mutation :causes resistance to activated protein C
Consider when no obvious signs for VTE/ PE
How would you investigate for PE?
Classification system? [1]
ECG? [3]
CXR? [1]
ABG [1]
o Wells Score greater than 4
ECG - sinus tachycardia, right heart strain. T-wave inversion on anterior leads (V1-V3). Classic finding: S (deep S wave in lead I), Q ( present in lead III) and T (inverted T in lead III).
o CXR- possible small pleural effusion, peripheral wedge shaped density above diaphragm, focal oligemia. Most common finding with PE patients is a normal CXR, but used to excludes other diagnoses
o ABG - often hypoxic, low CO2 (due to hyperventilation)